Related by context. Frequent words. (Click for all words.) 63 CORTOSS 58 Icatibant 57 MONOVISC 57 Marketing Authorization Application 57 Biologics License Application BLA 57 Zelrix 56 PREOS 56 FIRAZYR 56 alvimopan 56 Investigational Device Exemption 56 Aclasta 55 Loramyc ® 55 Rebif ® 55 ATryn ® 55 Investigational Device Exemption IDE 54 bazedoxifene 54 Rhucin ® 54 Vitaros 54 Ventavis 54 NOXAFIL 54 THELIN 54 Onsolis 54 Mitigation Strategy REMS 53 Marketing Authorization Application MAA 53 NEBIDO 53 Synvisc One 53 ONSOLIS 53 Drug Administration FDA 53 Exelbine 53 Medicinal Products EMEA 53 NUVIGIL 53 CE Marked 53 Zalbin 53 BLA submission 53 Mutual Recognition Procedure 53 supplemental Biologics License Application 53 Biologics License Application 53 FENTORA 53 LIALDA 53 ATryn R 53 OLEPTRO TM 53 PhosLo 52 NeutroSpec 52 SUMAVEL DosePro 52 Bepreve 52 investigational 52 Drug Administration USFDA 52 Telavancin 52 Prescribing Information 52 European Medicines Evaluation 51 BEMA Fentanyl 51 Microcyn Technology 51 orphan designation 51 prGCD 51 Relistor 51 Levulan PDT 51 Orphan Drug designation 51 Cimzia R 51 apaziquone 51 GEM #S 51 Vimpat 51 VIMOVO 51 Rhucin 51 Celsion Corporation 51 Avastin bevacizumab 51 Pirfenidone 51 Anturol 51 teduglutide 51 Vimovo 50 Nasdaq VRTX 50 QNEXA 50 Tracleer ® 50 silodosin 50 Entereg 50 JANUMET 50 taliglucerase alfa 50 oral anticoagulant 50 Thyrogen 50 f h 50 Advicor 50 sBLA 50 XEOMIN 49 FOSRENOL 49 alitretinoin 49 Foradil 49 Myobloc 49 Oracea 49 Horizant 49 Marketing Authorization 49 ANDA approvals 49 Renvela 49 Dysport ® 49 pediatric exclusivity 49 BioDelivery Sciences 49 BrachySil 49 Replagal 49 VPRIV 49 Mylotarg 49 Orphan Drug status 49 regadenoson 49 PFO closure